Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Deep Dive into Five Webcast / Podcast: Playing CLL/SLL Chess: Planning Your Therapy Moves

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Recorded November 30, 2022

Webcast / Podcast Description:

Treating CLL/SLL is a little like a chess game, as one needs to always be thinking a few moves ahead. Most treatments for CLL/SLL are not curative, and when relapse occurs it is important to have a plan in place with some options that can knock back the disease again.

Join CLL/SLL expert Dr. Susan O’Brien, and 22-year CLL survivor Terry Evans, for this fast-paced podcast / webcast as they dive deeper into this topic with five questions in roughly 15 minutes. Questions cover starting treatment, treatment options, determining your healthcare team, and how to better participate in shared decision-making.

This webcast / podcast is an additional resource built upon the webinar on this topic, found here. Increasing your knowledge and having a plan in place for your future treatment moves is part of you advocating for your best possible care. CLL Society believes Smart Patients Get Smart Care™.

Speaker

Susan O’Brien, MD
Professor of Medicine
University of California, Irvine

Moderator

Terry Evans
22-year CLL Patient and Advocate
Director, CLL Society Support Network

Our Partner

CLL Society has partnered with the National Association for Continuing Education (NACE) for the production of these educational resources.

Our Supporters

This program is made possible by support from BeiGene, Bristol Myers Squibb, Lilly Oncology, Genentech, and Janssen. 

Supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.